Kyowa Hakko, the ingredient manufacturer, joined forces with parent company Kirin Holdings to launch a new dietary supplement ingredient dubbed 'IMMUSE.' The new offering was designed for broad range immune support by activating plasmacytoid dendritic cells (pDC) which activates pivotal cells including Helper-T, NK, and Killer-T, among others.
IMMUSE is currently available on the market in Japan, sold in the form of functional beverages, tablets, gummies, and yogurt and is the first product in the country to display an immune-related function on the product.
The brands recently announced plans to expand into the US market, stating: "We could not be more thrilled to integrate the immune support benefits of IMMUSE into the US market. With more consumers looking for ways to enhance their immune system and stay healthy throughout the year, we are confident that IMMUSE... will open new doors for consumers desiring a novel option for brand range immune support."
Image Credit: Getty Images / Parfonovaluliia